Publications by authors named "Maxim D Oleynikov"

Claim this Profile
A
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention.
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Maxim D Oleynikov

J Neuroimmune Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostics for SARS-CoV-2 infections.
Bhavesh D Kevadiya, Jatin Machhi, Jonathan Herskovitz, Maxim D Oleynikov, Wilson R Blomberg

Nat Mater· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanocarrier vaccines for SARS-CoV-2.
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Maxim D Oleynikov

Adv Drug Deliv Rev· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacotherapeutics of SARS-CoV-2 Infections.
Bhavesh D Kevadiya, Jatin Machhi, Jonathan Herskovitz, Maxim D Oleynikov, Wilson R Blomberg

J Neuroimmune Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.
Jatin Machhi, Jonathan Herskovitz, Ahmed M Senan, Debashis Dutta, Barnali Nath, Maxim D Oleynikov

J Neuroimmune Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking.
Insiya Z Mukadam, Jatin Machhi, Jonathan Herskovitz, Mahmudul Hasan, Maxim D Oleynikov

Biomaterials· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis